20 articles
Combined therapy restored gut health in patients who failed conventional treatments, offering new hope for refractory IBD cases.
Nano-sized vesicles from a depleted gut bacterium rebalance immune cells and antibody transport in colitis, with taurine as the key metabolic link.
New research questions whether long-term HBIG therapy is necessary after liver transplantation, potentially simplifying post-transplant care.
A 13-year UK analysis of 273 liver transplant patients finds HBIG maintenance may be unnecessary, with NA-only prophylaxis offering a cost-effective alternative.
A double-blind RCT finds FMT capsules added to escitalopram reduce depression scores faster via bile acid and anti-inflammatory pathways.
Bacteriophages transferred during FMT may drive horizontal gene transfer, altering microbial function and antibiotic resistance in ways science has largely ignored.
Researchers develop innovative fluorescent approach to combat chronic hepatitis E, offering new hope for treatment-resistant infections.
A microbiome metabolite depleted by antipsychotics protects synapses and cognition — and supplementing it may reverse the damage.
Fecal transplants from cancer survivors significantly improved treatment outcomes for metastatic kidney cancer patients.
New research shows electroacupuncture improves motor function and protects brain cells in Parkinson's disease through protein regulation.
A microbial enzyme from Bifidobacterium enhances anti-TNF therapy efficacy in IBD by reshaping immune regulation via histone lactylation.
Real-world Australian study shows promising results for teduglutide in reducing dependency on IV nutrition in short bowel syndrome patients.
New real-world evidence reveals timing of hepatitis B treatment depends on infection subtype for optimal outcomes.
Regular physical activity slashes chronic pancreatitis risk and attenuates disease progression via muscle-derived vesicles that quiet pancreatic inflammation.
Small pilot study explores whether restoring gut bacteria can break the cycle of recurrent UTIs in women.
New research shows blocking PKM2 in immune cells promotes gut healing in colitis while preventing tumor formation.
Fecal microbiota transplants dramatically improved immune checkpoint inhibitor response rates in lung cancer and melanoma patients.
New research reveals how low tryptophan levels in portal blood create hyper-reactive immune cells that worsen liver damage in alcohol-related disease.
Bacterial metabolite from flavonoids protects against graft-versus-host disease while preserving anti-cancer effects in stem cell transplants.
Comprehensive review reveals specific probiotic strains effectively treat gut, liver, skin, mental health, and oral conditions based on clinical evidence.
